{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:19:36Z","timestamp":1790720376817,"version":"4.1.0"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.2967\/jnumed.123.265391","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T20:45:25Z","timestamp":1680813925000},"page":"1056-1061","source":"Crossref","is-referenced-by-count":28,"title":["Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors"],"prefix":"10.2967","volume":"64","author":[{"given":"Shadi A.","family":"Esfahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"De Aguiar Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priska","family":"Summer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"2023063006250736000_64.7.1056.1","doi-asserted-by":"publisher","DOI":"10.1159\/000080731"},{"key":"2023063006250736000_64.7.1056.2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40842-018-0066-3","article-title":"Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)","volume":"4","author":"Uri","year":"2018","journal-title":"Clin Diabetes Endocrinol."},{"key":"2023063006250736000_64.7.1056.3","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","article-title":"177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial","volume":"22","author":"Strosberg","year":"2021","journal-title":"Lancet Oncol."},{"key":"2023063006250736000_64.7.1056.4","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000000850"},{"key":"2023063006250736000_64.7.1056.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316158"},{"key":"2023063006250736000_64.7.1056.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2023063006250736000_64.7.1056.7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2003-0014"},{"key":"2023063006250736000_64.7.1056.8","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0078"},{"key":"2023063006250736000_64.7.1056.9","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.416"},{"key":"2023063006250736000_64.7.1056.10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2982"},{"key":"2023063006250736000_64.7.1056.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"2023063006250736000_64.7.1056.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510665"},{"key":"2023063006250736000_64.7.1056.13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MPA.0000000000001794","article-title":"Efficacy of checkpoint inhibitors in neuroendocrine neoplasms: Mayo Clinic experience","volume":"50","author":"Gile","year":"2021","journal-title":"Pancreas."},{"key":"2023063006250736000_64.7.1056.14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41416-020-0775-0","article-title":"Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials","volume":"122","author":"Vijayvergia","year":"2020","journal-title":"Br J Cancer."},{"key":"2023063006250736000_64.7.1056.15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3014"},{"key":"2023063006250736000_64.7.1056.16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1199"},{"key":"2023063006250736000_64.7.1056.17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2407"},{"key":"2023063006250736000_64.7.1056.18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3346"},{"key":"2023063006250736000_64.7.1056.19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11307-022-01763-9","article-title":"HER3 PET imaging predicts response to pan receptor tyrosine kinase inhibition therapy in gastric cancer","volume":"25","author":"Esfahani","year":"2023","journal-title":"Mol Imaging Biol."},{"key":"2023063006250736000_64.7.1056.20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11154-021-09647-z","article-title":"Present and future of immunotherapy in neuroendocrine tumors","volume":"22","author":"Albertelli","year":"2021","journal-title":"Rev Endocr Metab Disord."},{"key":"2023063006250736000_64.7.1056.21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/CMR.0000000000000386","article-title":"Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination","volume":"27","author":"Aboudaram","year":"2017","journal-title":"Melanoma Res."},{"key":"2023063006250736000_64.7.1056.22","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0517"},{"key":"2023063006250736000_64.7.1056.23","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","article-title":"Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial","volume":"2","author":"Parikh","year":"2021","journal-title":"Nat Cancer."},{"key":"2023063006250736000_64.7.1056.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262344"},{"key":"2023063006250736000_64.7.1056.25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67313"},{"key":"2023063006250736000_64.7.1056.26","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.211"},{"key":"2023063006250736000_64.7.1056.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.05.092"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.265391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T13:26:20Z","timestamp":1688131580000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.265391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,6,30]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.2967\/jnumed.123.265391"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.265391","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]}}}